quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:30:00·29d
PRRelease
Achieve Life Sciences Inc. logo

Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline's Receptor Selectivity to Low Nausea Rates and Favorable Tolerability

ACHV· Achieve Life Sciences Inc.
Health Care
Original source

Companies

  • ACHV
    Achieve Life Sciences Inc.
    Health Care

Recent analyst ratings

  • Apr 21UpdateCanaccord Genuity$13.00
  • Nov 25UpdateCitizens JMP$19.00
  • Aug 21UpdateH.C. Wainwright$12.00
  • Nov 14UpdateRodman & Renshaw$12.00
  • Sep 27UpdateRaymond James$20.00
  • May 10UpdateMaxim Group$20.00

Related

  • INSIDER2d
    SEC Form 4 filed by Goldberg Andrew D.
  • INSIDER2d
    SEC Form 3 filed by new insider Goldberg Andrew D.
  • ANALYST3d
    Canaccord Genuity initiated coverage on Achieve Life Sciences with a new price target
  • SEC7d
    Achieve Life Sciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
  • SEC7d
    SEC Form S-8 filed by Achieve Life Sciences Inc.
  • PR8d
    Achieve Life Sciences Announces Appointment of Andrew D. Goldberg, MD, as Chief Executive Officer and to the Board of Directors
  • PR8d
    Achieve Life Sciences Announces Up to $354 Million Private Placement
  • PR9d
    Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022